AWS
NVAX icon

Atria Wealth Solutions’s Novavax NVAX Stock Holding History

Atria Wealth Solutions’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,352
Closed -$49.5K – 2021
2024
Q1 		$49.5K Buy
+10,352
New +$48K ﹤0.01% 1924
2022
Q3 		– Sell
-18,730
Closed -$963K – 1826
2022
Q2 		$963K Buy
+18,730
New +$970K 0.02% 712

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Atria Wealth Solutions's NVAX Position: Q2 2024 in Review

Atria Wealth Solutions sold out of Novavax (NVAX) in Q2 2024, closing a stake of 10,352 shares — an estimated $49.5K sold.

Atria Wealth Solutions first reported a position in NVAX in Q2 2022 and held it in 2 quarters. The position peaked at $963K in Q2 2022. 229 funds tracked by Wall St. Rank hold NVAX as of Q2 2024.

  • Atria Wealth Solutions reported no remaining Novavax position as of Q2 2024 after selling out during the quarter.
  • Atria Wealth Solutions sold 10,352 Novavax shares in Q2 2024, an estimated $49.5K.
  • Atria Wealth Solutions first reported a position in Novavax in Q2 2022 and held it in 2 quarters.
  • Atria Wealth Solutions's Novavax position peaked at $963K in Q2 2022.
  • 229 funds tracked by Wall St. Rank held Novavax as of Q2 2024.

Based on Atria Wealth Solutions's 13F filing for Q2 2024, filed 22 Jul 2024.